26 research outputs found
New Insights into the Compositional Dependence of Li-Ion Transport in Polymer–Ceramic Composite Electrolytes
Composite electrolytes are widely
studied for their potential in realizing improved ionic conductivity
and electrochemical stability. Understanding the complex mechanisms
of ion transport within composites is critical for effectively designing
high-performance solid electrolytes. This study examines the compositional
dependence of the three determining factors for ionic conductivity,
including ion mobility, ion transport pathways, and active ion concentration.
The results show that with increase in the fraction of ceramic Li<sub>7</sub>La<sub>3</sub>Zr<sub>2</sub>O<sub>12</sub> (LLZO) phase in
the LLZO–polyÂ(ethylene oxide) composites, ion mobility decreases,
ion transport pathways transit from polymer to ceramic routes, and
the active ion concentration increases. These changes in ion mobility,
transport pathways, and concentration collectively explain the observed
trend of ionic conductivity in composite electrolytes. Liquid additives
alter ion transport pathways and increase ion mobility, thus enhancing
ionic conductivity significantly. It is also found that a higher content
of LLZO leads to improved electrochemical stability of composite electrolytes.
This study provides insight into the recurring observations of compositional
dependence of ionic conductivity in current composite electrolytes
and pinpoints the intrinsic limitations of composite electrolytes
in achieving fast ion conduction
Contents of 15 constituents in 7 decoctions.
<p>Contents of 15 constituents in 7 decoctions.</p
LC-MS/MS method validation for 15 constituents from BZ.
<p>LC-MS/MS method validation for 15 constituents from BZ.</p
Plasma concentration-time curves for psoralen, isopsoralen, psoralidin, xanthotoxin, and bergapten in SD rats after single oral administration of BZ.
<p>Plasma concentration-time curves for psoralen, isopsoralen, psoralidin, xanthotoxin, and bergapten in SD rats after single oral administration of BZ.</p
The drug–herb interaction network (D–H network) for BZ.
<p>BS, <i>P. corylifolia</i> and <i>C. monnieri</i>; BW, <i>P. corylifolia</i> and <i>A. carmichaelii</i>; BWS, <i>P. corylifolia</i>, <i>C. monnieri</i> and <i>A. carmichaelii</i>.</p
The chemical structures of 15 constituents in BZ.
<p>The chemical structures of 15 constituents in BZ.</p
Pharmacokinetic parameters of 5 constituents after single oral administration of BZ in SD rats.
<p>Pharmacokinetic parameters of 5 constituents after single oral administration of BZ in SD rats.</p
The drug–target association network (D–T network) for BZ.
<p>Green, the five compounds from BZ; Pink, the target-associated genes; Yellow, the shared genes among the five compounds.</p
Composite Polymer Electrolytes with Li<sub>7</sub>La<sub>3</sub>Zr<sub>2</sub>O<sub>12</sub> Garnet-Type Nanowires as Ceramic Fillers: Mechanism of Conductivity Enhancement and Role of Doping and Morphology
Composite polymer
solid electrolytes (CPEs) containing ceramic
fillers embedded inside a polymer-salt matrix show great improvements
in Li<sup>+</sup> ionic conductivity compared to the polymer electrolyte
alone. Lithium lanthanum zirconate (Li<sub>7</sub>La<sub>3</sub>Zr<sub>2</sub>O<sub>12</sub>, LLZO) with a garnet-type crystal structure
is a promising solid Li<sup>+</sup> conductor. We show that by incorporating
only 5 wt % of the ceramic filler comprising undoped, cubic-phase
LLZO nanowires prepared by electrospinning, the room temperature ionic
conductivity of a polyacrylonitrile-LiClO<sub>4</sub>-based composite
is increased 3 orders of magnitude to 1.31 × 10<sup>–4</sup> S/cm. Al-doped and Ta-doped LLZO nanowires are also synthesized
and utilized as fillers, but the conductivity enhancement is similar
as for the undoped LLZO nanowires. Solid-state nuclear magnetic resonance
(NMR) studies show that LLZO NWs partially modify the PAN polymer
matrix and create preferential pathways for Li<sup>+</sup> conduction
through the modified polymer regions. CPEs with LLZO nanoparticles
and Al<sub>2</sub>O<sub>3</sub> nanowire fillers are also studied
to elucidate the role of filler type (active vs passive), LLZO composition
(undoped vs doped), and morphology (nanowire vs nanoparticle) on the
CPE conductivity. It is demonstrated that both intrinsic Li<sup>+</sup> conductivity and nanowire morphology are needed for optimal performance
when using 5 wt % of the ceramic filler in the CPE
One-Pot Synthesis of Redox-Labile Polymer Capsules via Emulsion Droplet-Mediated Precipitation Polymerization
Monodisperse polyÂ(vinylcaprolactam)
(PVCL)-based capsules are prepared
by precipitation polymerization of vinylcaprolactam (VCL) onto dimethyldiethoxysilane
(DMDES) emulsion droplets and removal of the DMDES templates by ethanol.
Polymer chains in the shells can be cross-linked during the polymerization
by disulfide-containing cross-linker <i>N</i>,<i>N</i>′-bisÂ(acryloyl) cystamine, which endows the capsules with
an excellent redox-labile property. Versatility of this technique
to prepare capsules with diverse components is demonstrated by the
copolymerization of methacrylic acid (MAA) and VCL in the shell to
prepare polyÂ(vinylcaprolactam-<i>co</i>-methacrylic acid)
(PÂ(VCL-<i>co</i>-MAA)) capsules. The disulfide-bonded capsules
can degrade efficiently into low molecular weight species (ca. 1200
Da) when the capsules are incubated with 10 mM glutathione (GSH) as
the reducing agent. Delivery of the anticancer drug (doxorubicin,
DOX) was also investigated in the PÂ(VCL-<i>co</i>-MAA) capsules.
The cumulative <i>in vitro</i> release of DOX-loaded capsules
allows a relatively low DOX release at pH 7.4. However, a burst release
(ca. 90% in 6 h) of DOX was observed in the presence of 10 mM GSH.
Cell viability assays show that the PÂ(VCL-<i>co</i>-MAA)
capsules have negligible cytotoxicity to HeLa cancer cells. In comparison,
DOX-loaded PÂ(VCL-<i>co</i>-MAA) capsules cause significant
cell death following internalization. The reported capsules represent
a novel and versatile class of stimuli-responsive carriers for controlled
drug delivery